rs6350
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001044.5(SLC6A3):c.114C>T(p.Asn38Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0642 in 1,614,116 control chromosomes in the GnomAD database, including 3,584 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.059 ( 275 hom., cov: 33)
Exomes 𝑓: 0.065 ( 3309 hom. )
Consequence
SLC6A3
NM_001044.5 synonymous
NM_001044.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.485
Publications
49 publications found
Genes affected
SLC6A3 (HGNC:11049): (solute carrier family 6 member 3) This gene encodes a dopamine transporter which is a member of the sodium- and chloride-dependent neurotransmitter transporter family. The 3' UTR of this gene contains a 40 bp tandem repeat, referred to as a variable number tandem repeat or VNTR, which can be present in 3 to 11 copies. Variation in the number of repeats is associated with idiopathic epilepsy, attention-deficit hyperactivity disorder, dependence on alcohol and cocaine, susceptibility to Parkinson disease and protection against nicotine dependence.[provided by RefSeq, Nov 2009]
SLC6A3 Gene-Disease associations (from GenCC):
- classic dopamine transporter deficiency syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- SLC6A3-related dopamine transporter deficiency syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- parkinsonism-dystonia, infantileInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 5-1443084-G-A is Benign according to our data. Variant chr5-1443084-G-A is described in ClinVar as Benign. ClinVar VariationId is 522348.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.485 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0623 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC6A3 | ENST00000270349.12 | c.114C>T | p.Asn38Asn | synonymous_variant | Exon 2 of 15 | 1 | NM_001044.5 | ENSP00000270349.9 | ||
| SLC6A3 | ENST00000713696.1 | c.114C>T | p.Asn38Asn | synonymous_variant | Exon 2 of 15 | ENSP00000519000.1 | ||||
| SLC6A3 | ENST00000713698.1 | c.114C>T | p.Asn38Asn | synonymous_variant | Exon 2 of 5 | ENSP00000519002.1 | ||||
| SLC6A3 | ENST00000713697.1 | n.114C>T | non_coding_transcript_exon_variant | Exon 2 of 11 | ENSP00000519001.1 |
Frequencies
GnomAD3 genomes AF: 0.0587 AC: 8935AN: 152144Hom.: 275 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
8935
AN:
152144
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0556 AC: 13978AN: 251432 AF XY: 0.0574 show subpopulations
GnomAD2 exomes
AF:
AC:
13978
AN:
251432
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0648 AC: 94667AN: 1461854Hom.: 3309 Cov.: 34 AF XY: 0.0646 AC XY: 46946AN XY: 727234 show subpopulations
GnomAD4 exome
AF:
AC:
94667
AN:
1461854
Hom.:
Cov.:
34
AF XY:
AC XY:
46946
AN XY:
727234
show subpopulations
African (AFR)
AF:
AC:
1640
AN:
33480
American (AMR)
AF:
AC:
1631
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
1090
AN:
26136
East Asian (EAS)
AF:
AC:
507
AN:
39700
South Asian (SAS)
AF:
AC:
5241
AN:
86258
European-Finnish (FIN)
AF:
AC:
4160
AN:
53420
Middle Eastern (MID)
AF:
AC:
475
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
76019
AN:
1111972
Other (OTH)
AF:
AC:
3904
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
5431
10861
16292
21722
27153
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2828
5656
8484
11312
14140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0588 AC: 8950AN: 152262Hom.: 275 Cov.: 33 AF XY: 0.0602 AC XY: 4485AN XY: 74456 show subpopulations
GnomAD4 genome
AF:
AC:
8950
AN:
152262
Hom.:
Cov.:
33
AF XY:
AC XY:
4485
AN XY:
74456
show subpopulations
African (AFR)
AF:
AC:
2118
AN:
41544
American (AMR)
AF:
AC:
851
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
152
AN:
3472
East Asian (EAS)
AF:
AC:
83
AN:
5186
South Asian (SAS)
AF:
AC:
275
AN:
4824
European-Finnish (FIN)
AF:
AC:
891
AN:
10612
Middle Eastern (MID)
AF:
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4342
AN:
68008
Other (OTH)
AF:
AC:
133
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
429
859
1288
1718
2147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Classic dopamine transporter deficiency syndrome Benign:2
Apr 07, 2016
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Parkinsonism-dystonia, infantile Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.